Literature DB >> 11842680

The safe use of syringe drivers for palliative care: an action research project.

P J McCormack1, R Cooper, S Sutherland, H Stewart.   

Abstract

A palliative care team in north Scotland identified serious drug errors occurring in the local health-care trust. These were connected with the use of variable rate syringe drivers (IVAC P100) to deliver pain and symptom management rather than the more suitable Graseby MS26. An action research approach was taken to effecting change. An educational workshop was set up which 23 nurses attended. Clinical support was provided and 3 months later an evaluation was carried out. Of the 13 nurses who had used an MS26, most were able to correctly follow the process of setting up the driver and had made appropriate observations, but drug calculations were a problem. Change was stated to have taken place in seven clinical areas but the degree of change was variable. Facilitators and obstacles to the change process are identified and recommendations made for the next round in the action research cycle.

Entities:  

Mesh:

Year:  2001        PMID: 11842680     DOI: 10.12968/ijpn.2001.7.12.9289

Source DB:  PubMed          Journal:  Int J Palliat Nurs        ISSN: 1357-6321


  3 in total

1.  [Under what conditions is subcutaneous administration of fluid indicated].

Authors:  C Bausewein
Journal:  Internist (Berl)       Date:  2007-04       Impact factor: 0.743

2.  Appreciation of a Child's Journey: Implementation of a Cardiac Action Research Project.

Authors:  Kate Alexa Dengler; Valerie Wilson; Sarah Redshaw; Gabrielle Scarfe
Journal:  Nurs Res Pract       Date:  2012-04-29

3.  Mixed-methods study protocol: do national reporting and learning system medication incidents in palliative care reflect patient and carer concerns about medication management and safety?

Authors:  Sarah Yardley; Sally-Anne Francis; Antony Chuter; Stuart Hellard; Julia Abernethy; A Carson-Stevens
Journal:  BMJ Open       Date:  2021-09-13       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.